Digestive Enzyme Supplements Market To Reach $2.12 Billion By 2030

Digestive Enzyme Supplements Market Growth & Trends

The global digestive enzyme supplements market size is expected to reach USD 2.12 billion by 2030, expanding at a CAGR of 6.2% from 2025 to 2030, according to a new report published by Grand View Research, Inc. Growing consumer awareness regarding the severity of digestive disorders coupled with the need for good health is expected to stimulate industry growth over the forecast period. The increasing incidence of gastrointestinal tract diseases, such as irritable bowel syndrome, constipation, inflammatory bowel disease, and gastroesophageal reflux disease, has raised concerns towards stomach health, which in turn is anticipated to fuel product growth.

Digestive enzyme supplements have to comply with various regulatory bodies including the U.S. Food and Drug Administration, Dietary Supplement Health and Education Act of 1994, and Natural Health Products Regulations for manufacturing and use. Increasing number of gymnasiums and fitness centers in emerging markets including China and India on account of rising awareness towards muscle improvement and reducing fat content among individuals will propel product demand.

 Request a free sample copy or view report summary: Digestive Enzyme Supplements Market Report

Digestive Enzyme Supplements Market Report Highlights

• The animal-based digestive enzyme supplements segment will dominate the global industry in 2024. Unhealthy lifestyles, awareness regarding gut health and overall well-being, and increasing healthcare spending are adding to the growth of this segment.

• The additional supplements segment dominated the global digestive enzyme supplements industry in 2024. This is attributed to factors such as changing lifestyles, growing health consciousness among consumers, increasing demand from urban consumers, and more.

• The conventional nature segment held a significant revenue share of the global digestive enzyme supplements industry in 2024. Users prefer conventional products characterized by animal-based enzymes and tested formulations during treatment.

• North America dominated the global digestive enzyme supplements industry in 2024. This market is primarily driven by increasing demand from health-conscious urban consumers, growing utilization in the medical treatment associated with dietary ailments, and rising use in sports nutrition.

Digestive Enzyme Supplements Market Segmentation

Grand View Research has segmented the global digestive enzyme supplements market on the basis of origin, application, nature, and region:

Digestive Enzyme Supplements Origin Outlook (Revenue, USD Billion, 2018 - 2030)

• Animal

• Plant

• Microbial

• Others

Digestive Enzyme Supplements Application Channel Outlook (Revenue, USD Billion, 2018 - 2030)

• Additional Supplements

• Medical & Infant Nutrition

• Sports Nutrition

Digestive Enzyme Supplements Nature Outlook (Revenue, USD Billion, 2018 - 2030)

• Conventional

• Organic

Digestive Enzyme Supplements Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • U.K.

  • France

  • Italy

  • Spain

• Asia Pacific

  • China

  • India

  • Japan

  • Australia

• Latin America

  • Brazil

  • Argentina

• Middle East

  • South Africa

  • Saudi Arabia

List of Key Players in the Digestive Enzyme Supplements Market

• Enzymes, Inc.

• Amano Enzyme Inc.

• Enzymedica

• Klaire Laboratories

• National Enzyme Company

• Advanced Enzyme Technologies

• Metagenics

• Danone

• Integrative Therapeutics

• Vox Nutrition

• Klaire Laboratories